Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a …

C De Pasquale, ML Pistorio, M Veroux… - Neuropsychiatric …, 2014 - Taylor & Francis
Background Multiple sclerosis (MS) is a disease of the nervous system that has profound
effects on everyday functioning and quality of life of not only the person who is diagnosed …

Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study

K Kania, MA Pawlak, M Forycka… - Neurologia i …, 2024 - journals.viamedica.pl
Introduction. Cognitive impairment occurs from the earliest stages of multiple sclerosis (MS)
and progresses over time. The introduction of disease modifying therapies (DMTs) has …

[HTML][HTML] Prospective study of clinical, neurophysiological and urodynamic findings in multiple sclerosis patients undergoing percutaneous transluminal venous …

M Ulivelli, L Monti, M Ballerini, S Bartalini… - Clinical …, 2019 - Elsevier
Abstract Objective Verify whether Percutaneous Transluminal Angioplasty (PTA) may affect
neural conduction properties in Multiple Sclerosis (MS) patients, thereby modifying patients' …

Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangible

H Zwibel - Journal of the neurological sciences, 2009 - Elsevier
Multiple sclerosis is diagnosed primarily in young adults with aspirations for both family and
careers. For this reason, it is important to take into account the potential impact of disease …

Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study

F Patti, P Russo, A Pappalardo, F Macchia… - Journal of the …, 2007 - Elsevier
The Functional Assessment of Multiple Sclerosis (FAMS) quality of life (QoL) instrument is a
disease-specific, self-report questionnaire that was developed originally for US English …

Quality of life in multiple sclerosis in France, Germany, and the United Kingdom

N Murphy, C Confavreux, J Haas, N König… - Journal of Neurology …, 1998 - jnnp.bmj.com
OBJECTIVE To assess the quality of life (QoL) of patients with multiple sclerosis in France,
Germany, and the United Kingdom with a cross sectional study. METHODS Patients were …

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive …

F Patti, MP Amato, M Trojano… - Multiple Sclerosis …, 2009 - journals.sagepub.com
Background Cognitive impairment is a common symptom of multiple sclerosis (MS), but the
association between cognitive impairment and magnetic resonance imaging (MRI) disease …

[HTML][HTML] Cognitive function in multiple sclerosis: A long-term look on the bright side

Y Harel, A Kalron, S Menascu, D Magalashvili… - PloS one, 2019 - journals.plos.org
Background Multiple sclerosis (MS) may lead to cognitive decline over-time. Objectives
Characterize cognitive performance in MS patients with long disease duration treated with …

Cognition As a Parameter in Monitoring The Effect of Multiple Sclerosis Relapse Treatment: A Prospective Controlled Study

BP Cinar, C Baba, S Demir, C Uzunkopru… - Clinical Neurology and …, 2024 - Elsevier
Background Cognitive evaluation was considered to be very important in the relapse period,
on the basis of the presence of isolated cognitive attacks and the necessity of monitoring the …

Cognitive impairment in relapsing-remitting multiple sclerosis

B Topcular, M Ozcan, E Kurt, D Kuscu… - NOROPSIKIYATRI …, 2012 - avesis.istanbul.edu.tr
Objective: To assess the frequency of cognitive impairment in patients with
relapsingremittingmultipl e sclerosis (RRMS) using the Brief Repeatable Battery (BRB), as …